Two-label molecule record
Tirzepatide dose chart
Zepbound and Mounjaro contain the same active ingredient and share an adult numeric dose ladder. Their indications and the meaning attached to later doses are not the same, so CareCanon keeps both source records visible.
- Ingredient
- Tirzepatide
- Source labels
- 2 separate records
- Shared frequency
- Once weekly
- Last mirrored
- 2026-08-29T19:54:32.487Z
Answer first · adult label scope
2.5 mg starts both paths. The labels diverge in why a later dose is used.
Both captured labels start at 2.5 mg once weekly and state 5 mg after four weeks. A later increase is in 2.5 mg steps only after at least four weeks at the current dose; both name 15 mg once weekly as the adult maximum.
This is not an automatic 21-week plan. Zepbound ties selection to response and tolerability and names specific maintenance doses. Mounjaro ties further increases to additional glycemic control.
Earliest label-permitted steps
One numeric ladder. Two meanings.
The week shown is the earliest possible point after the label’s minimum four-week interval. It does not mean a person should increase at that point or continue to the next row.
| Earliest period | Dose | Zepbound label meaning | Mounjaro adult label meaning |
|---|---|---|---|
| Weeks 1–4 | 2.5 mg once weekly | Treatment initiation; not an approved maintenance dosage. | Treatment initiation; not intended for glycemic control. |
| Weeks 5–8 | 5 mg once weekly | Named maintenance option for weight reduction. | First post-initiation dosage. |
| Weeks 9–12 | 7.5 mg once weekly | Escalation step; not named as a maintenance dosage. | Further increase only if additional glycemic control is needed. |
| Weeks 13–16 | 10 mg once weekly | Named maintenance option for weight reduction. | Further increase only if additional glycemic control is needed. |
| Weeks 17–20 | 12.5 mg once weekly | Escalation step; not named as a maintenance dosage. | Further increase only if additional glycemic control is needed. |
| Week 21 onward | 15 mg once weekly | Named maintenance option and maximum dosage. | Adult maximum; only after label conditions for further control. |
Adult comparison only. The captured Mounjaro label separately names 10 mg once weekly as the maximum for pediatric patients 10 years and older.
Provenance before interpretation
Two labels, not one generic tirzepatide schedule.
Each card carries its own document identity, publication date, mirror date and DailyMed route. A future change to either source cannot silently rewrite the other.
tirzepatide · chronic weight management
ZEPBOUND
- Label published
- May 06, 2026
- Set ID
- 487cd7e7-434c-4925-99fa-aa80b1cc776b
- Rule checked
- 01/2026
- Mirrored
- 2026-08-29T19:54:31.296Z
tirzepatide · type 2 diabetes
MOUNJARO
- Label published
- May 06, 2026
- Set ID
- d2d7da5d-ad07-4228-955f-cf7e355c8cc0
- Rule checked
- 12/2025
- Mirrored
- 2026-08-29T19:54:32.487Z
Questions the chart must answer safely
Read the interval, then the condition.
Do Zepbound and Mounjaro use the same tirzepatide dose ladder?
The captured adult labels show the same numeric sequence from 2.5 mg through 15 mg, but they attach that sequence to different indications and dose-selection language. The brand records therefore remain separate.
Does the chart mean the dose increases every four weeks?
No. Four weeks is the minimum interval named by the labels before a later increase. It is not an instruction to advance automatically, and the labels attach additional response, tolerability or glycemic-control conditions.
What is the adult maximum tirzepatide dose in these labels?
Both captured labels name 15 mg once weekly as the adult maximum. The Mounjaro label separately names a 10 mg maximum for pediatric patients 10 years and older; this comparison table is adult-scoped.